Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Multicenter, Open-label, Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma

NCT01813136 is registered in ClinicalTrials.gov with Centre Leon Berard as lead sponsor.

NCT NCT01813136
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01813136 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Multicenter, Open-label, Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma
Lead sponsor
Centre Leon Berard
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2013
Completion date
January 31, 2019
Enrollment
168 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

thyroid carcinoma